Search research articles
Contact Us
Filters
Showing results (131-140 of 148) with videos related to
Page
of 15
Sort By:
Journal of the American College of Radiology : JACR
|
November 5, 2025
ACR Appropriateness Criteria® Staging and Disease Monitoring of Rectal Cancer
, Elena K Korngold, Avinash R Kambadakone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 27, 2017
Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan
Rebecca Suk Heist, Michael J Guarino, Gregory Masters, et al.
Annals of Surgical Oncology
|
August 17, 2019
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
Alice C Wei, Fang-Shu Ou, Qian Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2008
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial
William Small, Jordan Berlin, Gary M Freedman, et al.
BMC Cancer
|
November 3, 2023
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study
Do-Youn Oh, Maria Alsina Maqueda, David I Quinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2025
Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer
Kristen K Ciombor, Seong-Woo Bae, Jennifer G Whisenant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2017
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer
Aditya Bardia, Ingrid A Mayer, Jennifer R Diamond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2025
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors
Geoffrey Ku, Lin Shen, Farshid Dayyani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2023
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)
Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer, et al.
JAMA Oncology
|
April 21, 2022
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB): A Systematic Review and Delphi Consensus Statement
Esther N Pijnappel, J Annelie Suurmeijer, Bas Groot Koerkamp, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 148) with videos related to
Sort By:
Page
of 15
Journal of the American College of Radiology : JACR
|
November 5, 2025
ACR Appropriateness Criteria® Staging and Disease Monitoring of Rectal Cancer
, Elena K Korngold, Avinash R Kambadakone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 27, 2017
Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan
Rebecca Suk Heist, Michael J Guarino, Gregory Masters, et al.
Annals of Surgical Oncology
|
August 17, 2019
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
Alice C Wei, Fang-Shu Ou, Qian Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2008
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial
William Small, Jordan Berlin, Gary M Freedman, et al.
BMC Cancer
|
November 3, 2023
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study
Do-Youn Oh, Maria Alsina Maqueda, David I Quinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2025
Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer
Kristen K Ciombor, Seong-Woo Bae, Jennifer G Whisenant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2017
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer
Aditya Bardia, Ingrid A Mayer, Jennifer R Diamond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2025
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors
Geoffrey Ku, Lin Shen, Farshid Dayyani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2023
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)
Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer, et al.
JAMA Oncology
|
April 21, 2022
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB): A Systematic Review and Delphi Consensus Statement
Esther N Pijnappel, J Annelie Suurmeijer, Bas Groot Koerkamp, et al.
Page
of 15